Related Experiment Videos

Characterization of an E1A-CBP interaction defines a novel transcriptional adapter motif (TRAM) in CBP/p300

M J O'Connor1, H Zimmermann, S Nielsen

  • 1Institute of Molecular and Cell Biology, Singapore 117 609, Singapore. mcbomark@imcb.nus.edu.sg

Journal of Virology
|April 10, 1999
PubMed

Insights

Adenovirus E1A protein disrupts cell cycles by binding CBP/p300. A novel TRAM motif in CBP/p300 is key for E1A and transcription factor binding, offering a model for E1A

Area of Science:

  • Molecular biology
  • Virology
  • Cellular biology

Background:

  • Adenovirus E1A protein induces cell proliferation in quiescent cells.
  • CBP/p300 proteins are key transcriptional adapters and targets of E1A.
  • E1A may manipulate cell fate by competing for CBP/p300 binding sites.

Purpose of the Study:

  • To characterize the interaction between adenovirus E1A and CBP/p300.
  • To identify the binding sites and molecular mechanisms involved in E1A-mediated cellular manipulation.

Main Methods:

  • Protein interaction studies focusing on the C/H3 region of CBP.
  • Identification and characterization of a novel 12-residue transcriptional adapter motif (TRAM).
  • Peptide-based inhibition assays and in vivo studies using CBP TRAM fragments and p53.

Main Results:

  • A novel 12-residue TRAM within CBP/p300 serves as a binding site for E1A and transcription factors like p53, E2F, and TFIIB.
  • A specific sequence (FPESLIL) in E1A is essential for binding the CBP TRAM.
  • E1A peptides containing FPESLIL disrupt E1A-CBP interactions, inhibiting p53, E2F, and TFIIB binding.
  • In vivo, the CBP TRAM binds p53, disrupts MDM2-p53 interaction, stabilizing p53 and activating transcription.
  • Wild-type E1A, but not a binding-deficient mutant, inhibits E1A TRAM-mediated p53 transcriptional activation.

Conclusions:

  • The study defines a TRAM motif in CBP/p300 as a critical interaction hub for E1A and cellular transcription factors.
  • A molecular model for E1A's manipulation of cell fate via CBP/p300 interaction is proposed.
  • E1A antagonizes p53-mediated transcription by interfering with the CBP TRAM-p53 interaction.

Related Concept Videos